Prelude Therapeutics Incorporated announced a private placement with certain institutional accredited investors for issuance of 7,936,759 pre-funded warrants at a price of $3.1499 per warrant for gross proceeds of $24,999,997.1741 on December 11, 2023. The warrants have an exercise price of $0.0001 per share. The closing of the private placement is subject to customary closing conditions and is expected to occur on or about December 13, 2023.